TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
DarioHealth ( (DRIO) ) just unveiled an update.
DarioHealth Corp. announced that it has regained compliance with the Nasdaq’s minimum bid price requirement as of September 12, 2025. This development follows a period of non-compliance starting September 16, 2024, and signifies a positive turn for the company’s stock market standing, potentially stabilizing its position and reassuring stakeholders.
The most recent analyst rating on (DRIO) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on DarioHealth stock, see the DRIO Stock Forecast page.
Spark’s Take on DRIO Stock
According to Spark, TipRanks’ AI Analyst, DRIO is a Neutral.
DarioHealth’s overall stock score is primarily impacted by its financial challenges, including ongoing losses and high leverage. While technical indicators suggest a bearish trend, the company’s strategic initiatives and leadership changes provide some optimism for future growth.
To see Spark’s full report on DRIO stock, click here.
More about DarioHealth
Average Trading Volume: 15,500
Technical Sentiment Signal: Sell
Current Market Cap: $17.01M
Learn more about DRIO stock on TipRanks’ Stock Analysis page.